文献速递性腺与生殖内分泌

微小青春期卵巢与子宫形态及其与生殖激素的关联:一项纳入302名女婴的COPANA研究

Ovarian and Uterine Morphology in Minipuberty: Associations With Reproductive Hormones: a COPANA Study of 302 Girls.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究基于哥本哈根镇痛研究(COPANA)对302名3.4月龄健康女婴进行二次分析,采用经腹超声评估卵巢与子宫形态并检测生殖激素。结果发现窦卵泡总数与卵巢体积、抗苗勒管激素(AMH)、抑制素B正相关,与促卵泡激素(FSH)负相关;雌酮(E1)和雌二醇(E2)与乳腺组织直径相关。结论提示微小青春期下丘脑-垂体-性腺轴负反馈已建立,卵巢活动促进子宫与腺体乳腺组织生长,并提供可供临床使用的婴儿卵巢子宫形态正常值数据。

要点

  • 窦卵泡总数与卵巢体积(r=0.606)、AMH(r=0.378)、抑制素B(r=0.251)正相关,与FSH(r=-0.327)负相关。
  • ≥5 mm较大卵泡与AMH、抑制素B、E1、E2、孕酮、睾酮正相关,与FSH负相关。
  • E2与子宫内膜厚度相关(r=0.155,P=.020),E1和E2与乳腺组织直径相关(r=0.213和r=0.198,均P<.001)。

核心结论

  • 生殖激素与窦卵泡数量的相关性提示女性下丘脑-垂体-性腺轴的负反馈在微小青春期已建立,卵巢活动促进子宫和腺体乳腺组织生长。
  • 研究提供了可直接应用于临床的婴儿卵巢和子宫形态正常值数据。

研究设计与样本

  • 基于哥本哈根镇痛研究(COPANA,ClinicalTrials.gov NCT04369222)的二次分析,纳入302名健康女婴,平均年龄3.4月龄(标准差0.4)。
  • 经腹超声评估乳腺组织直径(n=300)、子宫体积(n=230)、子宫内膜厚度(n=255)、卵巢体积及窦卵泡计数(总数/2-4 mm/≥5 mm)(n=203)。
  • 血液样本(n=269/302=89%)检测AMH、FSH、LH、抑制素B(免疫分析)、孕酮、雄烯二酮、睾酮、E1、E2(液相色谱-串联质谱)。
  • 统计方法采用Pearson/Spearman相关系数(参数/非参数数据)。

主要发现

  • 窦卵泡总数与卵巢体积正相关(r=0.606;P<.001),与AMH正相关(r=0.378;P<.001),与抑制素B正相关(r=0.251;P<.001),与FSH负相关(r=-0.327;P<.001)。
  • ≥5 mm较大卵泡与AMH正相关(r=0.264;P<.001),与抑制素B正相关(r=0.230;P=.002),与E1正相关(r=0.209;P=.004),与E2正相关(r=0.269;P<.001),与孕酮正相关(r=0.160;P=.031),与睾酮正相关(r=0.210;P=.004),与FSH负相关(r=-0.183;P=.015)。
  • E1和E2水平与雌激素反应性组织大小相关:E2与子宫体积(r=0.134;P=.054),E2与子宫内膜厚度(r=0.155;P=.020),E1与乳腺组织直径(r=0.213;P<.001),E2与乳腺组织直径(r=0.198;P<.001)。

临床怎么用

  • 研究提供婴儿卵巢和子宫形态的正常值数据,可直接应用于临床设置。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Female minipuberty is characterized by complex dynamics of circulating reproductive hormones, while the relationship between ovarian and uterine morphology and reproductive hormones remains to be elucidated. OBJECTIVE: This work aimed to investigate the association between reproductive hormones and ovarian as well as uterine morphology by transabdominal ultrasound scan (TAUS) at minipuberty. METHODS: A secondary analysis was conducted from The Copenhagen Analgesic Study (COPANA) (ClinicalTrials.gov NCT04369222) of healthy infant girls (n = 302, aged 3.4 months [0.4] mean [±SD]: mamma tissue diameter [mm], n = 300). TAUS: uterine volume (n = 230), endometrial thickness (n = 255), ovarian volume, antral follicle count (total/2-4 mm/≥5 mm) (n = 203). Blood samples (n = 269/302 = 89%): antimüllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin B (immunoassays), progesterone (PROG), androstenedione (Adione), testosterone (T), estrone (E1), estradiol (E2) (liquid chromatography-tandem mass spectrometry). Statistics: Pearson/Spearman correlation coefficient (parametric/nonparametric data). RESULTS: Total follicle count correlated positively with ovarian volume (r = 0.606; P < .001), AMH (r = 0.378; P < .001), inhibin B (r = 0.251; P < .001), and negatively with FSH concentrations (r = -0.327; P < .001). Larger follicles (≥5 mm) correlated positively with AMH (r = 0.264; P < .001), inhibin B (r = 0.230; P = .002), E1 (r = 0.209; P = .004), E2 (r = 0.269; P < .001), PROG (r = 0.160; P = .031), and T (r = 0.210; P = .004) and negatively with FSH (r = -0.183; P = .015). Circulating E1 and E2 levels correlated with the size of estrogen-responsive tissue sizes: E2 vs uterine volume (r = 0.134; P = .054), E2 vs endometrial thickness (r = 0.155; P = .020), E1 and E2 vs mammary tissue diameter (r = 0.213 and r = 0.198, respectively; both P < .001). CONCLUSION: Correlations between reproductive hormones and the number of antral follicles suggest that negative feedback in the female hypothalamic-pituitary-gonadal axis is established during minipuberty, with ovarian activity promoting uterine and glandular breast tissue growth. We provide normative data of infant ovarian and uterine morphology directly implementable to a clinical setting.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Fischer MB, Mola G, Rom AL, et al. Ovarian and Uterine Morphology in Minipuberty: Associations With Reproductive Hormones: a COPANA Study of 302 Girls. J Clin Endocrinol Metab. 2025. PMID: 39329336. doi:10.1210/clinem/dgae678

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。